NIH is the World’s Largest Early Stage Life Sciences Investor That You Didn’t Know About

by & filed under Life Science, NVCA Blog, Public Policy.

What can NIH offer to NVCA member firm’s life science portfolio companies? How can you get access to NIH funded companies? Since when does NIH have Entrepreneurs in Residence? Check out the answers to these questions and more in our first Q&A session with NIH investment executives, Dr. Ethel Rubin and John Sullivan. To cultivate… Read more »

Timely Reauthorization of PDUFA & MDUFA Is Critical to VC-backed Life Science Breakthroughs

by & filed under Healthcare Innovation, NVCA Blog.

Thirty years ago, the median time for the Food and Drug Administration (FDA) approval of a new drug was 33 months. As one can imagine, major backlog at the agency caused significant delay to the approval and entry of potentially life-saving drugs in the market. To address this problem, Congress passed the Prescription Drug User… Read more »